Avenue Therapeutics Inc (ATXI)
2.075
-0.24
(-10.56%)
USD |
NASDAQ |
Oct 04, 16:00
2.09
+0.02
(+0.72%)
After-Hours: 20:00
Avenue Therapeutics Shareholders Equity (Annual): 1.582M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.582M |
| December 31, 2022 | 3.905M |
| December 31, 2021 | 3.451M |
| December 31, 2020 | 2.359M |
| December 31, 2019 | 6.80M |
| Date | Value |
|---|---|
| December 31, 2018 | -0.631M |
| December 31, 2017 | 19.38M |
| December 31, 2016 | -8.248M |
| December 31, 2015 | -5.135M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
1.582M
Minimum
2023
6.80M
Maximum
2019
3.619M
Average
3.451M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Fortress Biotech Inc | 22.54M |
| Checkpoint Therapeutics Inc | -13.05M |
| Journey Medical Corp | 20.35M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |